Insiders Trades
Cigna Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 12 Aug 2021.
Cigna Corp: what insiders have been doing
Cigna Corp, classified in the Healthcare & Pharma sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). No insider at Cigna Corp has published a filing in the past twelve months. The most recent one dates from 8 February 2023.
The full history, which starts in 2016, counts 1 purchase against 8 sales. The 10-K for the year ended 31 December 2025 shows 274.90 bn USD of revenue and 5.96 bn USD of net income and a dividend of 6.04 USD per share.
Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
133
Thresholds
n/a
Buy Volume
€89,519
1 ops. · all time
Sell Volume
€4M
8 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
Income statement
Revenue245.2B
Net income5.3B2.2% margin
Last declaration on 8 February 2023
Declarations133 total
200 shares0Common Stock, $.01 Par ValueSEC:0001225208-23-001581:0
50,700 shares0Common Stock, $.01 Par ValueSEC:0001225208-23-000595:0
3,009 shares@ US$139.2256.1% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-012918:0
9,781 shares@ US$197.3538.0% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-012577:0
2,452 shares0Common Stock, $.01 Par ValueSEC:0001225208-22-011589:0
373 shares@ US$300.0032.1% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-011022:0
4,000 shares@ US$300.00148.0% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-011021:0
902 shares@ US$285.4656.4% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-010384:0
6,060 shares@ US$139.2266.8% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-010321:0
1,749 shares0Common Stock, $.01 Par ValueSEC:0001225208-22-010083:0
7,044 shares@ US$58.7396.9% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-009439:0
374 shares@ US$285.0029.2% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-009440:0
902 shares@ US$273.989.9% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-009254:0
9,505 shares@ US$149.13528.8% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-008760:0
5,094 shares@ US$192.0239.6% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-008762:0
5,557 shares@ US$120.89525.8% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-008763:0
374 shares@ US$275.0028.3% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-008761:0
3,458 shares@ US$139.220.0006% mcap9.5% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-008322:0
45,261 shares@ US$120.89527.5% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-007209:0
5,901 shares@ US$139.2232.0% of flowCommon Stock, $.01 Par ValueSEC:0001225208-22-007208:0
757 shares0Common Stock, $.01 Par ValueSEC:0001225208-22-006301:0
757 shares0Common Stock, $.01 Par ValueSEC:0001225208-22-006305:0
757 shares0Common Stock, $.01 Par ValueSEC:0001225208-22-006307:0
757 shares0Common Stock, $.01 Par ValueSEC:0001225208-22-006300:0
757 shares0Common Stock, $.01 Par ValueSEC:0001225208-22-006306:0
25 of 133 declarations
About Cigna Corp
Cigna Corp, now operating under The Cigna Group, is one of the leading U.S. health care companies listed in the United States and traded on the NYSE under ticker CI. The company is headquartered in Bloomfield, Connecticut, United States. Over time, Cigna evolved from a traditional health insurer into a diversified managed health care platform that combines insurance coverage with pharmacy, clinical, and care-delivery services.
The group is organized around two core businesses: Cigna Healthcare and Evernorth Health Services. Cigna Healthcare provides medical, dental, behavioral health, Medicare-related, government, employer-sponsored, individual, and international health benefits. Evernorth Health Services houses the company’s health services platform, including pharmacy benefit management, specialty pharmacy, home delivery, clinical support services, and behavioral health solutions. This structure gives Cigna a distinctive competitive profile, because it captures both premium-based insurance revenue and service-based healthcare revenues, while also helping the group manage medical cost trends more actively.
Read moreShow less
From an investor perspective, Cigna’s appeal lies in the breadth of its platform, the recurring nature of its customer relationships, and its ability to integrate benefits administration with care services. Its product set includes medical plans, pharmacy solutions, dental and vision coverage, behavioral health programs, wellness tools, cost-management programs, and digital health offerings. The company serves employers, government programs, consumers, brokers, consultants, and health care providers, with a broad footprint in the United States and selected international markets. The latest annual report shows that the vast majority of external revenue is generated in the United States, underscoring the company’s primarily domestic earnings base.
Recent developments have centered on portfolio optimization, clinical access initiatives, and capital management. In 2025, Cigna Healthcare announced executive leadership changes and continued to highlight programs aimed at improving access to care, including digital musculoskeletal care and behavioral health support. The company also remained active in balance-sheet management, including debt tender activity previously disclosed by management. Overall, Cigna remains a major name in the Health Care sector, supported by its scale, integrated model, and strong positioning in a highly regulated, competitive U.S. market where affordability, network breadth, and care coordination are critical differentiators.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
